Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vacc-4x versus placebo in ART-suppressed adults with HIV-1
2007-006302-13Phase 2Completed
- Sponsor
- Immunor
- Start
- Jan 2008
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Human immunodeficiency virus infection type 1 comparing Vacc-4x arm with Placebo arm (2 arms). Primary endpoint: Proportion restarting antiretroviral therapy. Started Jan 2008; status: completed.
02
Drugs
Vacc-4x
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-006302-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006302-13.